CIK: 1120477 - Address: C/O Protagonist Therapeutics, Inc., 7707 Gateway Blvd., Suite 140, Newark, CA 94560-1160
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

4/2/24 20:29
4/1/24
PTGXProtagonist Therapeutics, IncDEHealthDrugPharmaceutical PreparationsPatel Dinesh V Ph DCADOP,CEOS-70828.310-25-4550D
3/1/24 20:46
3/1/24
PTGXProtagonist Therapeutics, IncDEHealthDrugPharmaceutical PreparationsPatel Dinesh V Ph DCADOP,CEOS-94931.620-30-5575D
12/15/23 16:30
12/13/23
PTGXProtagonist Therapeutics, IncDEHealthDrugPharmaceutical PreparationsPatel Dinesh V Ph DCADOP,CEOS-1,50620.080-75-12534D
12/23/21 16:17
12/21/21
PTGXProtagonist Therapeutics, IncDEHealthDrugPharmaceutical PreparationsPatel Dinesh V Ph DCADOP,CEOS-48232.140-15-3477D
1/20/21 20:20
1/19/21
PTGXProtagonist Therapeutics, IncDEHealthDrugPharmaceutical PreparationsPatel Dinesh V Ph DCADOP,CEOS.d-61124.600-25-6426D
8/8/19 18:15
8/6/19
PTGXProtagonist Therapeutics, IncDEHealthDrugPharmaceutical PreparationsPatel Dinesh V Ph DCADOP,CEOS-968.850-11-3375D
3/4/19 18:33
3/1/19
PTGXProtagonist Therapeutics, IncDEHealthDrugPharmaceutical PreparationsPatel Dinesh V Ph DCADOP,CEOS.d-188.030-2-1384D
2/8/19 17:37
2/6/19
PTGXProtagonist Therapeutics, IncDEHealthDrugPharmaceutical PreparationsPatel Dinesh V Ph DCADOP,CEOS-847.740-11-3357D
12/21/17 19:54
12/21/17
PTGXProtagonist Therapeutics, IncHealthDrugPharmaceutical PreparationsPatel Dinesh V Ph DCADOP,CEOS.d-16119.560-8-4190D
12/20/17 21:28
12/20/17
PTGXProtagonist Therapeutics, IncHealthDrugPharmaceutical PreparationsPatel Dinesh V Ph DCADOP,CEOS.d-3519.550-2-1190D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact